Introduction
​Maintaining oral health is crucial for overall well-being, and dentists play a vital role in ensuring the longevity and strength of our teeth. However, certain medications used to treat various conditions can pose a risk to the health of the jawbone, leading to a condition known as medication-related osteonecrosis of the jaw (MRONJ). This article will explore the incidence and prevention of MRONJ, providing valuable insights for patients and dental professionals alike.
Understanding Medication-Related Osteonecrosis of the Jaw (MRONJ)
Osteonecrosis is a condition where the jawbone experiences a lack of blood supply, leading to the death of bone tissue. MRONJ specifically refers to this condition when it is associated with the use of certain medications, primarily bisphosphonates and antiresorptive drugs.
These medications are commonly prescribed for the treatment of osteoporosis, Paget’s disease, certain types of cancer, and other conditions that affect bone metabolism. While these medications are essential for managing these health issues, they can also disrupt the natural bone remodeling process, increasing the risk of MRONJ.
Incidence of MRONJ
The incidence of MRONJ varies depending on the specific medication, dosage, and route of administration. Studies have shown that the risk is generally higher for patients taking intravenous (IV) bisphosphonates compared to those taking oral bisphosphonates.
For patients receiving IV bisphosphonates for the treatment of cancer, the incidence of MRONJ can range from 0.8% to 12%. In contrast, the incidence for patients taking oral bisphosphonates for the treatment of osteoporosis is estimated to be between 0.01% and 0.06%.
It’s important to note that the risk of MRONJ is not limited to the initial stages of treatment. The condition can also develop years after the discontinuation of these medications, highlighting the need for ongoing monitoring and preventive measures.
Risk Factors for MRONJ
Several factors can increase the risk of developing MRONJ, including:
-
Type and Duration of Medication: As mentioned, the risk is generally higher for patients taking IV bisphosphonates or receiving higher doses of these medications.
-
Dental Procedures: Certain dental procedures, such as tooth extractions, implant placement, or periodontal surgery, can trigger the onset of MRONJ, particularly in high-risk patients.
-
Underlying Medical Conditions: Conditions like diabetes, cancer, or autoimmune disorders can further increase the risk of MRONJ.
-
Poor Oral Hygiene: Maintaining good oral hygiene and regular dental visits are crucial in preventing the development of MRONJ.
-
Smoking: Tobacco use has been associated with an increased risk of MRONJ, as it can impair wound healing and bone regeneration.
Symptoms and Diagnosis of MRONJ
The early signs of MRONJ may include:
- Exposed or necrotic bone in the oral cavity
- Pain, swelling, or infection in the affected area
- Difficulty chewing or swallowing
- Loose teeth or tooth mobility
In more advanced cases, patients may experience:
- Fistulas or oro-antral communications
- Pathological fractures of the jawbone
- Osteolysis (bone loss) visible on radiographic imaging
To diagnose MRONJ, dentists and dental specialists will conduct a thorough clinical examination and may order radiographic imaging, such as panoramic radiographs or cone-beam computed tomography (CBCT), to assess the extent of the condition.
Prevention and Management of MRONJ
The prevention and management of MRONJ involve a collaborative approach between patients and their healthcare team, including dentists, physicians, and other specialists.
Preventive Measures
-
Pre-treatment Dental Evaluation: Patients who are about to start taking bisphosphonates or other antiresorptive medications should undergo a comprehensive dental examination and any necessary dental treatments, such as fillings, root canals, or tooth extractions, before initiating the medication.
-
Optimal Oral Hygiene: Patients should maintain excellent oral hygiene by brushing, flossing, and receiving regular professional cleanings (prophylaxis). This helps minimize the risk of dental infections that could trigger MRONJ.
-
Regular Dental Visits: Patients should schedule regular dental check-ups and cleanings to detect and address any oral health issues promptly.
-
Minimizing Invasive Dental Procedures: If possible, dentists should avoid performing invasive dental procedures, such as tooth extractions or implant placements, in patients taking bisphosphonates or other antiresorptive medications.
-
Antibiotic Prophylaxis: In some cases, dentists may recommend antibiotic prophylaxis before and after certain dental procedures to reduce the risk of MRONJ.
Management of Established MRONJ
-
Discontinuation or Dose Adjustment: In consultation with the patient’s physician, the medication regimen may be adjusted or temporarily discontinued to support the healing process.
-
Conservative Approach: The initial management of MRONJ typically involves a conservative approach, focusing on pain management, antibiotic therapy, and minimally invasive procedures to promote healing.
-
Surgical Intervention: In more advanced or refractory cases, surgical intervention may be necessary to remove the necrotic bone and promote healing. This should be performed by an experienced oral and maxillofacial surgeon.
-
Adjunctive Therapies: Depending on the severity of the condition, dentists may recommend adjunctive therapies, such as hyperbaric oxygen therapy, platelet-rich plasma (PRP) therapy, or teriparatide therapy, to support bone healing and regeneration.
-
Patient Education and Ongoing Monitoring: Patients with MRONJ should be educated about the condition and the importance of maintaining excellent oral hygiene and regular dental visits during and after the treatment process. Ongoing monitoring is essential to detect and manage any recurrences or complications.
Real-Life Case Scenarios
Case 1: Preventive Measures for a Patient Starting Bisphosphonate Therapy
Mrs. Smith, a 68-year-old woman, was recently diagnosed with osteoporosis and was prescribed oral bisphosphonate medication. Before starting the medication, she visited Station Road Dental Aldergrove for a comprehensive dental evaluation.
During the examination, the dentist noted that Mrs. Smith had several dental fillings that were in need of replacement, as well as some gum inflammation (gingivitis). The dentist recommended that Mrs. Smith undergo a thorough dental cleaning (prophylaxis) and have the necessary fillings replaced before starting the bisphosphonate therapy.
By addressing these dental issues proactively, the dentist reduced Mrs. Smith’s risk of developing MRONJ later on. The dentist also provided Mrs. Smith with detailed instructions on maintaining excellent oral hygiene and scheduling regular dental check-ups during her bisphosphonate treatment.
Case 2: Surgical Management of MRONJ
Mr. Johnson, a 72-year-old man, had been taking IV bisphosphonate medication for the treatment of metastatic prostate cancer for several years. He visited Station Road Dental Aldergrove with complaints of pain and exposed bone in his lower jaw.
After a comprehensive clinical examination and radiographic imaging, the dentist diagnosed Mr. Johnson with stage 3 MRONJ. The dentist consulted with Mr. Johnson’s oncologist and recommended a surgical intervention to remove the necrotic bone and promote healing.
The oral and maxillofacial surgeon performed the procedure, carefully excising the affected bone and ensuring the surgical site was clean and free of infection. Mr. Johnson was prescribed antibiotic therapy and pain medication to manage the post-operative discomfort.
During the follow-up visits, the dentist closely monitored the healing process and provided interim prosthetic solutions to address the functional and aesthetic concerns. With the collaborative efforts of the dental team and the patient’s oncologist, Mr. Johnson’s MRONJ was successfully managed, and he was able to continue his cancer treatment.
Conclusion
Medication-related osteonecrosis of the jaw is a serious condition that can have a significant impact on a patient’s oral and overall health. By understanding the incidence, risk factors, and preventive measures, both patients and dental professionals can work together to mitigate the risk of MRONJ and ensure the best possible outcomes for those requiring bisphosphonate or other antiresorptive medications.
Regular dental check-ups, maintaining excellent oral hygiene, and proactive interventions before and during medication regimens are crucial in preventing the development of MRONJ. Should the condition arise, a collaborative approach between the patient, dentist, and other healthcare providers is essential for effective management and treatment.
At Station Road Dental Aldergrove, we are committed to providing comprehensive and personalized dental care, including the prevention and management of MRONJ. Our team of experienced dentists and specialists are dedicated to ensuring the long-term oral health and well-being of our patients.
